<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:doc-ZHMTWVEY</identifier><date>2010</date><creator>Premuš Marušič, Alenka</creator><relation>documents/doc/Z/URN_NBN_SI_doc-ZHMTWVEY_001.htm</relation><relation>documents/doc/Z/URN_NBN_SI_doc-ZHMTWVEY_001.pdf</relation><relation>documents/doc/Z/URN_NBN_SI_doc-ZHMTWVEY_001.txt</relation><format format_type="issue">2</format><format format_type="volume">61</format><format format_type="type">article</format><format format_type="extent">str. 86-90</format><identifier identifier_type="ISSN">0014-8229</identifier><identifier identifier_type="COBISSID">24148775</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-ZHMTWVEY</identifier><language>slv</language><publisher>Slovensko farmacevtsko društvo</publisher><source>Farmacevtski vestnik</source><rights>InC</rights><subject language_type_id="slv">anksiolitiki</subject><subject language_type_id="slv">antidepresivi</subject><subject language_type_id="slv">antipsihotiki</subject><subject language_type_id="eng">drug</subject><subject language_type_id="slv">duševne motnje</subject><subject language_type_id="slv">interakcije</subject><subject language_type_id="slv">zdravila</subject><title>Drug Interactions with drugs used to treat mental disorders</title><title>Interakcije z zdravili za zdravljenje duševnih motenj</title></Record>